Sitagliptin and Metformin Tablet
|
Generic Name |
Sitagliptin and Metformin |
|---|---|
|
Strength |
50 mg + 1000 mg / 50 mg + 500 mg |
|
Form |
Tablet |
|
Packaging |
1 x 10 Tablets |
|
Therapeutic use |
Anti Diabetic, Type 2 diabetes |
|
Manufacturing Period |
30 to 45 Days |
Available Composition of
| Name | Strength | Therapeutic use | View More |
|---|---|---|---|
| Linagliptin and Metformin HCl Tablet | 2.5 mg + 1000 mg, 2.5 mg + 500 mg, 2.5 mg + 850 mg, 5 mg + 500 mg | Anti Diabetic | |
| Voglibose and Metformin Tablet | 0.2 mg + 1000 mg, 0.2 mg + 500 mg, 0.3mg + 1000 mg, 0.3 mg + 500 mg | Anti Diabetic | |
| Glimepiride, Pioglitazone and Metformin Tablet | 2 mg + 500 mg + 7.5 mg, 1 mg + 500 mg + 15mg, 2 mg + 500 mg + 15 mg | Anti Diabetic | |
| Glimepiride, Metformin and Voglibose Tablet | 1 mg + 500 mg + 0.2 mg, 2 mg + 500 mg + 0.2 mg | Anti Diabetic | |
| Gliclazide and Metformin Tablet | 60 mg + 500 mg, 80 mg + 500 mg | Anti Diabetic | |
| Glibenclamide and Metformin Tablet | 2.5 mg + 500 mg, 5 mg + 500 mg | Anti Diabetic | |
| Sitagliptin Tablet | 25 mg, 50 mg, 100 mg | Anti Diabetic | |
| Empagliflozin and Metformin Tablet | 12.5 mg + 500 mg | Anti Diabetic | |
| Pioglitazone and Metformin HCL Tablet | 15 mg + 500 mg | Anti Diabetic, Type 2 diabetes | |
| Sitagliptin and Metformin Tablet | 50 mg + 1000 mg, 50 mg + 500 mg | Anti Diabetic, Type 2 diabetes |
Product Description For Sitagliptin and Metformin Tablet
products details and uses
Sitagliptin and Metformin Exporter India, Manufacturer, Wholesaler & Distributor
Sitagliptin and Metformin Tablets are a combination oral medication used to effectively manage high blood sugar levels in patients with type 2 diabetes mellitus. This dual-action formula combines Sitagliptin, a DPP-4 inhibitor that increases insulin release and decreases glucose production, with Metformin, a biguanide that improves insulin sensitivity and reduces glucose absorption.
Together, this combination helps control blood sugar levels, reduces the risk of diabetes-related complications such as kidney damage, nerve problems, vision loss, and may also lower the risk of heart attack and stroke in diabetic patients.
Global Distribution Network
With a strong logistics and compliance framework, we successfully export Sitagliptin and Metformin to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey